• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nemaura Medical Inc. - Common Stock (NQ:NMRD)

0.1053 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nemaura Medical Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) UK licensee, MySugarWatch, Begins Direct-to-Consumer Campaign in Daily Mail
May 17, 2022
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
May 13, 2022
On Friday, 153 companies set new 52-week lows. 
Via Benzinga
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Launch of Physician-Focused Ads as Part of Large-Scale Campaign Around sugarBEAT(R)
May 03, 2022
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at Planet MicroCap Showcase 2022
April 25, 2022
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Nemaura Medical's (NASDAQ: NMRD) Technologies Stand Distinct ↗
April 04, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Nemaura Medical’s (NASDAQ: NMRD) Technologies Stand Distinct
April 04, 2022
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Technologies Stand Distinct
April 01, 2022
Via Investor Brand Network
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022 ↗
March 29, 2022
Upgrades 
Via Benzinga
News headline image
Nemaura To Participate At Maxim Group Virtual Growth Conference ↗
March 25, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... 
Via Benzinga
Nemaura (NASDAQ: NMRD) to Participate at Maxim Group Virtual Growth Conference
March 25, 2022
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate at Upcoming Maxim Group 2022 Virtual Growth Conference
March 25, 2022
Via Investor Brand Network
News headline image
Nemaura Medical Bringing Valuable AI-Powered Insights To Diabetes Market ↗
March 23, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Bringing Valuable AI-Powered Insights to Diabetes Market
March 23, 2022
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Bringing Valuable AI-Powered Insights to Diabetes Market
March 22, 2022
Via Investor Brand Network
News headline image
Nemaura Enters Commercialization Phase Of Development ↗
March 21, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Nemaura (NASDAQ: NMRD) Enters Commercialization Phase of Corporate Development
March 21, 2022
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Enters Commercialization Phase of Its Corporate Development, Recognizes First-Ever Revenues
March 18, 2022
Via Investor Brand Network
News headline image
Nemaura Medical's sugarBEAT(R) CGM Device Met With Early Success ↗
March 14, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... 
Via Benzinga
Nemaura Medical’s (NASDAQ: NMRD) sugarBEAT(R) CGM Device Met with Early Success
March 14, 2022
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Revolutionary sugarBEAT(R) CGM Device Met with Early Success
March 11, 2022
Via Investor Brand Network
News headline image
Nemaura Medical Recognized As Innovator Of The Year ↗
March 01, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Recognized as Innovator of the Year
March 01, 2022
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Recognized as Innovator of the Year, Awarded Top Honors for Innovation in MedTech, Life Sciences
February 28, 2022
Via Investor Brand Network
News headline image
Nemaura Medical Producing What Was Thought To Be Implausible ↗
February 24, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD) has long... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Producing What Was Thought to Be Implausible
February 24, 2022
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Producing What Was Thought to Be Implausible
February 23, 2022
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Seeks to Provide Non-Invasive Glucose Monitoring Solutions Worldwide
February 18, 2022
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Seeks to Provide Non-Invasive Glucose Monitoring Solutions to Millions of Patients Worldwide
February 17, 2022
Via Investor Brand Network
News headline image
Nemaura Reports Financial Results, Business Updates for Q3 2022 ↗
February 15, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Nemaura (NASDAQ: NMRD) Reports Financial Results, Business Updates for Q3 2022
February 15, 2022
Via Investor Brand Network
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap